EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSNFUG00015005613
Gene Symbol: IDH2
1 Cross references
186 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSNFUG00015007968
Gene Symbol: LOC107388798
3 Cross references
207 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSNFUG00015011864
Gene Symbol: KEAP1B
1 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor (A Type Iii Receptor Tyrosine Kinase)

Ensembl ID : ENSNFUG00015013724
Gene Symbol: KDR
1 Cross references
197 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSNFUG00015012927
Gene Symbol: KIF5B
1 Cross references
231 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSNFUG00015019705
Gene Symbol: KIF5B
3 Cross references
236 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSNFUG00015009842
Gene Symbol: LTA4H
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSNFUG00015022749
Gene Symbol: LOC107383490
3 Cross references
167 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSNFUG00015018881
Gene Symbol: LOC107377158
3 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSNFUG00015018877
Gene Symbol: LOC107377157
3 Cross references
142 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSNFUG00015017788
Gene Symbol: LOC107387768
3 Cross references
200 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSNFUG00015004877
Gene Symbol: KDM1A
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).